Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - EPS
EPS HALO - Halozyme Therapeutics, Inc.
3.5
LAST VALUE
53.78%
2 YEAR CAGR
55.18%
5 YEAR CAGR
23.49%
10 YEAR CAGR